Axa’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $457K | Buy |
2,090
+1,046
| +100% | +$229K | ﹤0.01% | 993 |
|
|
2025
Q1 | $234K | Sell |
1,044
-124
| -11% | -$27.8K | ﹤0.01% | 1009 |
|
|
2024
Q4 | $383K | Buy |
1,168
+94
| +9% | +$30.8K | ﹤0.01% | 966 |
|
|
2024
Q3 | $322K | Sell |
1,074
-16,875
| -94% | -$5.07M | ﹤0.01% | 1003 |
|
|
2024
Q2 | $5.91M | Buy |
17,949
+1,964
| +12% | +$647K | 0.02% | 497 |
|
|
2024
Q1 | $6.33M | Sell |
15,985
-6,657
| -29% | -$2.63M | 0.02% | 506 |
|
|
2023
Q4 | $7.97M | Sell |
22,642
-22,075
| -49% | -$7.77M | 0.03% | 444 |
|
|
2023
Q3 | $16.8M | Sell |
44,717
-20,077
| -31% | -$7.53M | 0.06% | 306 |
|
|
2023
Q2 | $24.8M | Buy |
64,794
+19,370
| +43% | +$7.41M | 0.08% | 250 |
|
|
2023
Q1 | $15.7M | Sell |
45,424
-99,871
| -69% | -$34.6M | 0.05% | 330 |
|
|
2022
Q4 | $34.2M | Buy |
145,295
+99,969
| +221% | +$23.5M | 0.12% | 200 |
|
|
2022
Q3 | $11.2M | Sell |
45,326
-72,706
| -62% | -$17.9M | 0.04% | 410 |
|
|
2022
Q2 | $35.7M | Sell |
118,032
-21,589
| -15% | -$6.53M | 0.13% | 178 |
|
|
2022
Q1 | $57.3M | Sell |
139,621
-21,689
| -13% | -$8.91M | 0.16% | 150 |
|
|
2021
Q4 | $75.7M | Buy |
161,310
+47,985
| +42% | +$22.5M | 0.19% | 124 |
|
|
2021
Q3 | $48.1M | Sell |
113,325
-67,553
| -37% | -$28.7M | 0.14% | 186 |
|
|
2021
Q2 | $65M | Buy |
180,878
+66,993
| +59% | +$24.1M | 0.18% | 136 |
|
|
2021
Q1 | $32.1M | Sell |
113,885
-7,953
| -7% | -$2.24M | 0.1% | 247 |
|
|
2020
Q4 | $34.5M | Buy |
121,838
+56,549
| +87% | +$16M | 0.11% | 217 |
|
|
2020
Q3 | $17.9M | Sell |
65,289
-35,799
| -35% | -$9.84M | 0.06% | 310 |
|
|
2020
Q2 | $23M | Buy |
101,088
+31,288
| +45% | +$7.11M | 0.09% | 245 |
|
|
2020
Q1 | $10.6M | Buy |
69,800
+54,900
| +368% | +$8.36M | 0.05% | 352 |
|
|
2019
Q4 | $2.24M | Buy |
+14,900
| New | +$2.24M | 0.01% | 788 |
|